SEC Filing Update: #SYRE Spyre Therapeutics, Inc. : $102.50

Sector: Healthcare | YTD: 🔼+ 234.86% The SEC disclosed Today (14-AUG-2026) that RTW INVESTMENTS LP has INCREASED #SYRE Shares by 1.92% 🟢 * Previous Holdings: 4.17M Shares * Current Holdings: 4.25M Shares * Increase+80.00K * Increased(%)+1.92% * Ownership: 4.8% * Estimated Investment Value: $8.23M https://www.thinksabio.com/reports/isr/SYRE Institutional ownership in #SYRE has been steadily rising over the past 13 quarters in Shares: Q4 2023: 28.01M Q1 2024: 32.38M Q2 2024: 50.39M Q3 2024: 51.38M Q4 2024: 59.88M Q1 2025: 62.11M Q2 2025: 63.62M Q3 2025: 64.30M Q4 2025: 80.98M Q1 2026: 82.65M The quarterly average prices of #SYRE: Q3 2025: $16.30 Q4 2025: $26.02 Q1 2026: $37.69